Alvi MA, Liu X, O'Donovan M, Newton R, Wernisch L, Shannon NB, Shariff... |
DNA methylation as an adjunct to histopathology to detect prevalent, inconspicuous dysplasia and early-stage neoplasia in Barrett's esophagus |
|
Clin Cancer Res. |
Amankwah EK, Lin HY, Tyrer JP, Lawrenson K, Dennis J, Chornokur G, et al. |
Epithelial-Mesenchymal Transition (EMT) Gene Variants and Epithelial Ovaria... |
Friday, September 25, 2015 |
Genetic epidemiology |
Amin Al Olama A, Benlloch S, Antoniou AC, Giles GG, Severi G, Neal DE, et a... |
Risk Analysis of Prostate Cancer in PRACTICAL, a Multinational Consortium, ... |
Saturday, April 4, 2015 |
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology |
Amin Al Olama A, Dadaev T, Hazelett DJ, Li Q, Leongamornlert D, Saunders EJ... |
Multiple novel prostate cancer susceptibility signals identified by fine-ma... |
Sunday, May 31, 2015 |
Human molecular genetics |
An Q, Burke GA, Dainton M, Harrison CJ, Kempski H, Konn Z, Myooren W, Stewa... |
Haploinsufficiency of the MLL and TOB2 genes in lymphoid malignancy |
|
Leukemia |
Anca M Farcas, Sankari Nagarajan, Sabina Cosulich, and Jason S Carroll |
Genome-Wide Estrogen Receptor Activity in Breast Cancer |
Sunday, December 20, 2020 |
Endocrinology |
Anderson ND, de Borja R, Young MD, Fuligni F, Rosic A, Roberts ND, Hajjar S... |
Rearrangement bursts generate canonical gene fusions in bone and soft tissue tumors |
Friday, August 31, 2018 |
Science |
Andrews LJ, Thornton ZA, Saincher SS, Yao IY, Dawson S, McGuinness LA, Jone... |
Prevalence of BRAFV600 in glioma and use of BRAF Inhibitors in patients wit... |
Thursday, October 28, 2021 |
Neuro Oncol |
Anjomani Virmouni S, Al-Mahdawi S, Sandi C, Yasaei H, Giunti P, Slijepcevic... |
Identification of telomere dysfunction in Friedreich ataxia |
Thursday, June 11, 2015 |
Molecular neurodegeneration |
Anna E Hakes, Andrea H Brand |
Tailless/TLX reverts intermediate neural progenitors to stem cells driving tumourigenesis via repression of asense/ASCL1 |
Wednesday, February 19, 2020 |
eLife |